Advertisement
Entire Site
Articles/Fact Sheets
Ask the Experts
Conference Coverage
Library of Older Articles
Track Your CD4 Count and Viral Load!
Use TheBody.com's New Health Tracker!
HIV/AIDS Basics & Prevention
HIV/AIDS Basics & Prevention
Basics & Prevention: Home
HIV/AIDS Basics
HIV Prevention
HIV Testing
Who Gets HIV/AIDS?
Myths About HIV/AIDS
More ...
Just Diagnosed
Just Diagnosed
Just Diagnosed: Home
Choosing a Physician
Coping
HIV Hotlines & Orgs
Telling Others
More ...
HIV Treatment
HIV Treatment
HIV Treatment: Home
Drug Resistance
HIV Medications
Side Effects & Health Problems
Starting Treatment
Women & Pregnancy
More ...
Living With HIV
Living With HIV
Living With HIV: Home
Arts & Entertainment
Beyond Medications
Inspiring Stories
Mental Health
More ...
AIDS Policy & Activism
AIDS Policy & Activism
HIV Policy & Activism: Home
Activist Central
Medicine Recycling
U.S.-Specific News
Developing World News
More ...
HIV Around the World
HIV Around the World
HIV Around the World: Home
Africa
Asia
Latin America
U.S. and Canada
Western Europe
More ...
Conference Coverage
Conference Coverage
Conference Coverage: Home
CROI 2009
ICAAC/IDSA 2008
Previous Conferences
Upcoming Conferences
More ...
E-Mail
Glossary
Share
Close Share
Digg This!
Google Bookmarks
Save to del.icio.us
Twitter
Share on Facebook
Submit to reddit
StumbleUpon
Technorati
Close Share
Nelfinavir (Viracept) Research
See also:
Medication Side Effects
|
Drug Interactions
Show Archived (Historical) Articles
ACTG 384 Substudy: DEXA Outcomes in Antiretroviral-Naive Patients Randomized to Efavirenz or Nelfinavir or Both Plus Nucleoside Backbone
(August 16, 2006)
In
XVI International AIDS Conference
E-Mail
Glossary
Share
Close Share
Digg This!
Google Bookmarks
Save to del.icio.us
Twitter
Share on Facebook
Submit to reddit
StumbleUpon
Technorati
Close Share
Advertisement